News
The company announced that VIZZ (aceclidine ophthalmic solution) 1.44% received FDA approval as the first and only aceclidine-based eye drop for treating blurry near vision. Lenz plans to make samples ...
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...
They say: A fan-favourite gets a new name. The Canadian skin care brand’s Dew Drops serum has the new name Jelly Drops, but ...
Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results